Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Jul 26, 2026
Bloom Energy (BE) Drops -26.6% Over 30 Days: Short-Seller Report and Sector Rotation Weigh on Shares

Bloom Energy (BE) Drops -26.6% Over 30 Days: Short-Seller Report and Sector Rotation Weigh on Shares

Key Takeaways

  • Bloom Energy shares dropped approximately 26.6% over the trailing 30 days, closing at $184.89 on July 24, 2026, down from $252.02 on June 26.
  • A short-seller report from Hunterbrook Capital on July 7, targeting the company's scandium supply chain, triggered the initial wave of selling pressure.
  • Reports of project delays involving key customers Oracle and American Electric Power compounded negative sentiment, raising concerns about revenue timing.
  • A broader selloff across fuel-cell and AI-power stocks accelerated the decline, with the sector experiencing heavy profit-taking after a parabolic rally earlier in 2026.
  • Despite the pullback, Bloom Energy's underlying AI data-center power demand thesis remains intact, backed by a recently expanded $25 billion partnership with Brookfield Asset Management.
  • The upcoming Q2 earnings report on July 28 is viewed as a critical catalyst that could either restore confidence or deepen the selloff.

Bloom Energy (BE) Company Overview and Market Position

Bloom Energy Corporation designs, manufactures, and deploys solid oxide fuel cell systems for on-site power generation. Its flagship product, the Bloom Energy Server, converts natural gas, biogas, or hydrogen into electricity through an electrochemical reaction, providing customers with a reliable, low-carbon alternative to traditional grid power. The company serves a diverse range of industries including data centers, healthcare, manufacturing, and utilities, and has emerged as a key beneficiary of surging AI-driven electricity demand. Investors closely follow BE because of its strategic positioning at the intersection of clean energy and artificial intelligence infrastructure, two of the most consequential investment themes of the decade. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Bloom Energy (BE) Stock Price Performance: Last 30 Days vs. Quarter

Bloom Energy shares have endured a sharp reversal over the past 30 days. From a closing price of $252.02 on June 26, 2026, the stock fell to $184.89 by July 24, marking a decline of roughly 26.6%. The selloff accelerated in mid-July following a short-seller report and continued through a broad-based retreat in fuel-cell and AI-related equities. Daily trading volume surged well above average during several sessions, signaling elevated institutional repositioning and risk reduction. From what I see, the move highlights how quickly sentiment can shift in high-growth names.

Zooming out to the quarterly picture, the stock has fallen approximately 20% from levels around $231 in late April. However, this quarterly figure masks enormous intra-quarter volatility. After reporting blockbuster Q1 results on April 28 — including 130.4% year-over-year revenue growth and sharply raised full-year guidance — shares soared from around $226 to an all-time high of $351.28 by mid-June. The subsequent collapse erased nearly half of that peak value, transforming what was a banner quarter into a cautionary tale about high-multiple stocks and execution risk.

What Drove BE Stock Price in the Last 30 Days

The 30-day decline was ignited by a short-seller report from Hunterbrook Capital, disclosed on July 7, which challenged Bloom Energy's claims regarding its scandium supply chain. Scandium oxide is a critical stabilizer in the company's solid oxide fuel cell ceramic electrolyte. Hunterbrook alleged that Bloom's assertions of independence from Chinese scandium sourcing were contradictory, and that global scandium supply constraints could limit the company's ability to scale manufacturing to meet ambitious production targets. The report struck a nerve because it attacked the integrity of the core product story rather than merely questioning valuation.

Bloom Energy's COO Satish Chitoori responded publicly, stating the company sources scandium from industrial tailings and that existing supply chains can support up to 25 gigawatts of production. Analysts at Baird and UBS defended the stock with price targets of $310 and $350 respectively. Nevertheless, the damage to sentiment was done.

Shortly thereafter, TD Cowen analyst Jeff Osborne flagged meaningful delays at two major projects. Oracle's 2.45-gigawatt data center buildout reportedly lacked an approved air permit and faced a natural gas pipeline dispute with federal regulators, while AEP's timeline near Cheyenne, Wyoming, slipped by roughly two years. Then, on July 20, reports surfaced that New Mexico state authorities had rejected a key natural gas pipeline permit tied to Oracle's Project Jupiter, raising the possibility that Bloom Energy's fuel-cell deployment timeline for the project could be pushed into the following year.

The final blow came from a broad sector rotation. On July 24, fuel-cell stocks suffered a sweeping selloff as traders unwound crowded AI-power positions. Bloom Energy fell 14.9% in a single session, dragging peers FuelCell Energy and Plug Power down alongside it. The absence of a single negative catalyst that day suggested the move was driven by high-beta profit-taking amid a risk-off macro environment. One thing that stands out is how quickly these rotations can cascade through the group.

What Drove BE Stock Performance Over the Last Quarter

The quarterly narrative for Bloom Energy is defined by a dramatic boom-and-bust cycle. The period began with the company's Q1 2026 earnings report on April 28, which exceeded virtually every expectation. Revenue surged to $751.1 million, product revenue jumped 208.4%, and management raised full-year revenue guidance from approximately 60% growth to 80% at the midpoint. Non-GAAP operating income guidance was lifted from a range of $425-$475 million to $600-$750 million. These numbers validated the thesis that Bloom Energy was becoming the go-to solution for on-site data center power in an era of grid constraints.

Two mega-partnerships anchored the bull case. The Oracle collaboration was expanded to cover up to 2.8 gigawatts of fuel-cell capacity for AI cloud infrastructure. Meanwhile, the Brookfield Asset Management AI infrastructure partnership grew from $5 billion to $25 billion, signaling enormous institutional conviction in Bloom's technology. These announcements, combined with the earnings beat, propelled the stock to its all-time high of $351.28 in mid-June.

Yet the same quarter revealed the vulnerabilities of a stock priced for perfection. At its peak, Bloom Energy traded at approximately 26 times forward sales. The short-seller report, project delay headlines, insider selling totaling approximately $44 million over 90 days, and a rotation out of high-momentum AI names all converged to puncture that premium valuation. The stock's beta of 3.73 amplified every downdraft, turning what could have been a moderate correction into a rout. I’m watching this closely because valuation resets like this often set up the next leg of moves.

BE Stock Forecast Drivers: What Investors Should Watch Next

The most immediate catalyst for Bloom Energy is its Q2 2026 earnings report scheduled for July 28 after market close. Consensus estimates call for revenue around $766-833 million, and investors will closely scrutinize whether the company can deliver another guidance raise in light of the expanded Brookfield partnership. Management commentary on the Oracle and AEP project timelines, the scandium supply chain, and the pace of new contract wins will be pivotal.

Beyond earnings, the trajectory of AI capital expenditure remains the dominant macro driver. Any slowdown in hyperscaler spending or a shift in power procurement strategies could disproportionately affect Bloom Energy given its premium valuation. On the regulatory front, a June FERC ruling instructing grid operators to accommodate on-site power generation represents a potential tailwind. Investors should also monitor insider trading patterns, institutional ownership changes, and any further short-seller scrutiny. The stock currently trades at approximately 14 times forward sales — more reasonable than its peak but still demanding execution with minimal margin for error.

Using AI Tools to Navigate Volatility

In fast-moving markets like the one currently surrounding Bloom Energy, I often look to AI-driven tools to help identify patterns and manage risk. Tickeron’s Trending AI Robots page features a curated selection of top-performing AI trading bots drawn from a universe of hundreds of automated strategies that trade thousands of tickers across equities, ETFs, and forex. Only the bots demonstrating the strongest recent performance and relevance make it into this featured section. Each bot operates with its own distinct strategy, timeframe, and risk profile — ranging from short-term momentum models to longer-term trend-following systems — giving traders a diversified view of AI-generated signals. Exploring this page can offer valuable insight into how algorithmic strategies are navigating volatile stocks like BE.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: BE

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


BE in upward trend: 10-day moving average moved above 50-day moving average on September 09, 2026

The 10-day moving average for BE crossed bullishly above the 50-day moving average on September 09, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 02, 2026. You may want to consider a long position or call options on BE as a result. In 61 of 74 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.

BE moved above its 50-day moving average on September 03, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +4.39% 3-day Advance, the price is estimated to grow further. Considering data from situations where BE advanced for three days, in 266 of 309 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.

The Aroon Indicator entered an Uptrend today. In 242 of 262 cases where BE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.

Bearish Trend Analysis

The 10-day RSI Indicator for BE moved out of overbought territory on September 10, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 42 similar instances where the indicator moved out of overbought territory. In 35 of the 42 cases, the stock moved lower in the following days. This puts the odds of a move lower at 83%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 50 of 59 cases where BE's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 85%.

The Moving Average Convergence Divergence Histogram (MACD) for BE turned negative on October 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 33 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 73%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.

BE broke above its upper Bollinger Band on September 25, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 33 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. BE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 44 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 94 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 100 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: BE's P/B Ratio (48.077) is very high in comparison to the industry average of (7.529). BE's P/E Ratio (341.390) is considerably higher than the industry average of (54.807). Projected Growth (PEG Ratio) (0.594) is also within normal values, averaging (2.900). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (24.876) is also within normal values, averaging (8.080).

Notable companies

The most notable companies in this group are Bloom Energy Corp (NYSE:BE), Plug Power (NASDAQ:PLUG), FuelCell Energy Inc (NASDAQ:FCEL), GrafTech International Ltd (NYSE:EAF).

Industry description

The industry produces a diverse range of electricity-powered equipment, appliances and components, catering to both households and industries. The products include power, distribution and specialty transformers; electric motors, generators and motor-generator sets; switchgear and switchboard apparatus; light bulbs, tubes, fittings and electric signs etc. Consumer income, construction spending, and industrial production are major drivers of demand for this industry’s products. Large companies tend to have economies of scale in production, marketing, and distribution, while smaller companies can potentially carve out their own market through niche or specialty offerings. The US electrical products manufacturing industry includes about 5,700 establishments (single-location companies and units of multi-location companies) with combined annual revenue of about $125 billion. (according to a study published in First Research). Emerson Electric Co., Hubbell Incorporated and Eaton Corporation plc are major electrical products makers in the U.S.

Market Cap

The average market capitalization across the Electrical Products Industry is 5.46B. The market cap for tickers in the group ranges from 750 to 205.24B. CYATY holds the highest valuation in this group at 205.24B. The lowest valued company is EDYYF at 750.

High and low price notable news

The average weekly price growth across all stocks in the Electrical Products Industry was -0%. For the same Industry, the average monthly price growth was -7%, and the average quarterly price growth was -8%. NEOV experienced the highest price growth at 30%, while EPOW experienced the biggest fall at -31%.

Volume

The average weekly volume growth across all stocks in the Electrical Products Industry was -21%. For the same stocks of the Industry, the average monthly volume growth was 21% and the average quarterly volume growth was -23%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 55
P/E Growth Rating: 74
Price Growth Rating: 63
SMR Rating: 84
Profit Risk Rating: 85
Seasonality Score: 20 (-100 ... +100)
View a ticker or compare two or three
BE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of on-site electric power solutions

Industry ElectricalProducts

Industry
Electrical Products
Address
4353 North First Street
Phone
+1 408 543-1500
Employees
2214
Web
https://www.bloomenergy.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
From what I see, Cheniere Energy Partners (CQP) holds a commanding position through its ownership and operation of the Sabine Pass LNG terminal in Louisiana, the largest LNG production facility in the U.S. with approximately 30 million tonnes per annum (mtpa) capacity across six trains, alongside the connected Creole Trail Pipeline. This setup makes CQP a leader in U.S. LNG exports, which have accounted for about 11% of global supply in recent years. The company's ~80% contracted production through long-term sale and purchase agreements (SPAs) provides revenue stability, with weighted average remaining lives of around 13 years.
In my view, Regeneron Pharmaceuticals holds a strong leadership position in biotechnology, thanks to its proprietary VelociSuite technologies, including VelocImmune for fully human antibody discovery. This enables a robust pipeline across immunology, oncology, ophthalmology, and rare diseases. The company's integrated model—from discovery to commercialization—drives high R&D productivity, with approximately 45 clinical programs and key partnerships like Sanofi for Dupixent and Bayer for EYLEA.
As I review argenx SE's place in the market, its strong footing in immunology stands out. This commercial-stage biopharmaceutical company focuses on differentiated antibody therapies for severe autoimmune diseases. The flagship product, VYVGART (efgartigimod), a first-in-class neonatal Fc receptor (FcRn) inhibitor, has secured leadership in generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), with approvals across the U.S., Europe, and Japan. The Immunology Innovation Program (IIP) fuels a robust pipeline, featuring next-generation FcRn candidates like ARGX-213 and ARGX-124, alongside first-in-class assets such as empasiprubart (C2 inhibitor, ARGX-117) and adimanebart (MuSK agonist).
I've long admired Alnylam Pharmaceuticals as the pioneer in RNA interference (RNAi) therapeutics, a gene-silencing technology that has delivered six approved products, including AMVUTTRA (vutrisiran), ONPATTRO (patisiran), GIVLAARI (givosiran), and OXLUMO (lumasiran). The company's proprietary platform, enhanced by GalNAc conjugation for liver targeting and emerging extra-hepatic delivery innovations, creates a solid competitive moat in precision genetic medicines.
As I review BeOne Medicines AG's position in the oncology space, what stands out is its role as a global leader with a diversified portfolio that includes both commercial-stage therapies and a deep pipeline targeting hematologic and solid tumors. The flagship product, BRUKINSA (zanubrutinib), a Bruton's Tyrosine Kinase (BTK) inhibitor, has secured approvals in over 75 markets, solidifying its dominance in chronic lymphocytic leukemia (CLL) and other blood cancers. This is complemented by TEVIMBRA (tislelizumab), an anti-PD-1 antibody approved in more than 50 markets for various indications, which broadens its reach in immunotherapy.
Rio Tinto holds a premier position as one of the world's largest mining companies, anchored by low-cost, Tier 1 assets. Its Pilbara iron ore operations in Australia deliver industry-leading margins, thanks to integrated rail and port infrastructure that gives it a structural cost advantage over higher-cost producers. In copper, the company has significant stakes in Escondida, the world's largest copper mine, and full ownership of Oyu Tolgoi in Mongolia, setting it up well to benefit from tightening supply as demand surges for electrification and renewables.
I've always been impressed by how Visa (V) commands the global payments landscape. As an open-loop network, it connects issuers, acquirers, merchants, and consumers without issuing cards or extending credit itself. The VisaNet platform processes over 65,000 transactions per second across more than 200 countries, supporting a ~52% share of the global credit card market and ~60% of debit. This scale generates powerful network effects, where greater adoption benefits everyone involved and creates formidable barriers to entry.
Following the Kenvue consumer health spin-off, Johnson & Johnson has transformed into a focused healthcare leader, emphasizing Innovative Medicine (pharmaceuticals) and MedTech (devices). In my view, this repositioning sharpens the company's edge in high-margin areas such as oncology, immunology, neuroscience, cardiovascular, surgery, and vision, where its diversified portfolio and R&D efficiency provide clear competitive advantages.
I've long appreciated ASML Holding N.V.'s dominant position in the semiconductor lithography market. The company commands over 90% share in advanced deep ultraviolet (DUV) immersion systems and 100% in EUV lithography—the critical technology for chips below 7nm nodes used in AI, high-performance computing, and memory. This near-monopoly comes from decades of R&D investment, exclusive partnerships like Zeiss for optics, and a vast installed base that generates steady service revenue. From what I see, competitors such as Nikon and Canon remain far behind in EUV, sticking to mature nodes.
I've been watching Micron Technology (MU) closely through its recent volatility, which mirrors the semiconductor sector's heightened sensitivity to AI demand and supply constraints. The stock saw a sharp post-earnings sell-off tied to elevated capital expenditure plans, yet it has rebounded with surging DRAM prices—up 90-95%—and memory suppliers booked out for years. From what I see, broader tech optimism, including key partnerships and persistent supply tightness, is driving upward momentum. This positions MU as a pivotal player in high-bandwidth memory (HBM) for data centers. Trading near recent highs around $368, the shares highlight investor focus on Micron's critical role in the AI infrastructure expansion under these constrained industry conditions.
Bloom Energy (BE) Drops -26.6% Over 30 Days: Short-Seller Report and Sector Rotation Weigh on Shares